MedTrace Logo

Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema

NCT02691507 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2017-03-06

Study results available
· View outcomes & findings →

Summary

The objective of this 1 week trial is to evaluate the efficacy of an over-the-counter (OTC) 1% colloidal oatmeal skin protectant cream in adults and children with mild to moderate AD.

Conditions

Interventions

DEVICE

EpiCeram Skin Barrier Emulsion

EpiCeram Skin Barrier Emulsion

DRUG

Experimental Product 1% Colloidal Oatmeal Balm

Experimental Product 1% Colloidal Oatmeal Balm

Sponsors & Collaborators

  • Johnson & Johnson Consumer Inc. (J&JCI)

    lead INDUSTRY

Principal Investigators

  • Amisha Parikh-Das, PhD · Johnson & Johnson Consumer Inc. (J&JCI)

  • Lily Jiang, PhD · Stephens & Associates, Inc (Texas Research Center)

  • Kun M Qian, MD · Stephens & Associates, Inc (Colorado Research Center)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02691507 on ClinicalTrials.gov